Telemedical Assistance in Automatic Titration of Oxygen for Intensive Care Patients

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to clinically validate a system for the monitoring of patients' respiratory function and automated oxygen treatment proposal using non-invasive ventilation devices in the treatment of intensive care patients with acute or chronic lung diseases exacerbations. Participants clinical parameters will be monitored and samples will be sent to a clinical laboratory for analysis (arterial blood pressure, heart rate, and respiratory rate will be continuously recorded, and FeO2 and CO2 will be measured with the help of an additional sensor).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• signed informed consent to participate in the study;

• aged over 18 years;

• patients hospitalized with acute respiratory failure (indication to NIV therapy) with restrictive or obstructive lung disease

Locations
Other Locations
Latvia
Pauls Stradins Clinical Univeristy Hospital
RECRUITING
Riga
Time Frame
Start Date: 2023-03-01
Estimated Completion Date: 2023-11-30
Participants
Target number of participants: 30
Treatments
Experimental: CPAP/APAP INTERVENTION WITH AND WITHOUT OXYGEN SUPPORT
Patients in this group will be selected from the Sleep Disorder Center database for printing data on hypoxemia below 90% during the night and for treatment received (CPAP/APAP and/or oxygen therapy). And from available data in PSCUH data systems on patient diagnoses, previous results of studies (results of blood gas tests), and recommended treatments on hospital and outpatient disease cards, which will include indications of possible chronic hypoxemia. The selected patients will be called (telephone visit) and, if agreed, will be scheduled for study time. Consequently, if the consent questionnaire was signed, a study will be launched following an evaluation of the inclusion and exclusion criteria.
Sponsors
Leads: Pauls Stradins Clinical University Hospital

This content was sourced from clinicaltrials.gov